retatrutide eli lilly press release 2024 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation retatrutide clinical trial results 2024
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18















:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)











